NCT07738887
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07738887 |
| Title | Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations (EVITA) |
| Acronym | EVITA |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | The Lymphoma Academic Research Organisation |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA | BEL |
CKB BOOST